These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14098708)

  • 21. On the structure of the stable complex between plasmin and alpha-2-antiplasmin.
    Nilsson T; Wiman B
    FEBS Lett; 1982 Jun; 142(1):111-4. PubMed ID: 6213426
    [No Abstract]   [Full Text] [Related]  

  • 22. [ON THE BEHAVIOR OF PLATELET ANTIPLASMIN IN CONSTITUTIONAL THROMBOPATHY (VON WILLEBRAND-JUERGENS SYNDROME)].
    JUERGENS J
    Verh Dtsch Ges Inn Med; 1964; 70():630-2. PubMed ID: 14294285
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hemostatic tests for the diagnosis of thrombosis. Activated coagulation and fibrinolytic factors. Detection of the protease/inhibitor complex].
    Iijima K
    Rinsho Byori; 1988 Jun; 36(6):623-6. PubMed ID: 2974894
    [No Abstract]   [Full Text] [Related]  

  • 24. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P; de Boer A; Verstreken M; Collen D
    Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [ON THE OCCURRENCE OF SOMATIC DISEASES AND THE NEED FOR NURSING CARE FOR THE BODY IN MENTAL HOSPITALS].
    ASK O
    Sven Lakartidn; 1963 Dec; 60():3743-59. PubMed ID: 14103146
    [No Abstract]   [Full Text] [Related]  

  • 26. Investigation of the enzymatic activity in rheumatoid arthritis. II. The antiplasmin action of serum in patients with rheumatoid arthritis.
    HAMMARSTEN G; JONSSON E
    Acta Med Scand; 1954; 147(5-6):363-6. PubMed ID: 13157912
    [No Abstract]   [Full Text] [Related]  

  • 27. A REVIEW OF UNUSUAL SYSTEMIC MANIFESTATIONS ASSOCIATED WITH CARCINOMA.
    GREENBERG E; DIVERTIE MB; WOOLNER LB
    Am J Med; 1964 Jan; 36():106-20. PubMed ID: 14120080
    [No Abstract]   [Full Text] [Related]  

  • 28. On the changes of plasmin activity caused by radiation treatment in cancer patients and effects of antiplasmin (ipsilon) administration.
    YAMASHITA H; IGARI S; TANAKA T
    Keio J Med; 1961 Dec; 10():195-207. PubMed ID: 14008905
    [No Abstract]   [Full Text] [Related]  

  • 29. Partial purification of bovine antiplasmin (antifibrinolysin).
    COLE ER; DALBY A; MERTZ ET
    Can J Biochem Physiol; 1960 Sep; 38():1021-7. PubMed ID: 13811110
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ultra-micro-determination of plasmin using a fibrin plate. 3. Relationship to antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Dec; 19(12):859-62. PubMed ID: 4258880
    [No Abstract]   [Full Text] [Related]  

  • 31. [Alpha 2-plasmin inhibitor-plasmin complex].
    Yoshikawa Y
    Nihon Rinsho; 1999 Sep; 57 Suppl():685-7. PubMed ID: 10543213
    [No Abstract]   [Full Text] [Related]  

  • 32. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
    Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [FIBRINOLYSIS AND ANTIFIBRINOLYTIC THERAPY IN UROLOGIC OPERATIONS. EXAMINATIONS USING A NEW METHOD FOR MEASURING FIBRINOLYSIS].
    PIPER W; BUCHBERGER HG; SIMON S; KRUEGER J
    Med Welt; 1965 Feb; 8():385-96. PubMed ID: 14262868
    [No Abstract]   [Full Text] [Related]  

  • 34. [About degradation products of the inter-alpha-trypsin inhibitor in serum. I. The inter-alpha-trypsin inhibitor as precursor of the acid stable trypsin-plasmin-inhibitor of the serum (author's transl)].
    Hochstrasser K; Niebel J; Feuth H; Lempart K
    Klin Wochenschr; 1977 Apr; 55(7):337-42. PubMed ID: 140269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increased complexes between protease and protease inhibitor in the plasma from patients with neoplasm].
    Okadome T; Maruyama I; Shinmyouzu K; Jounosono M; Osame M
    Rinsho Ketsueki; 1988 Dec; 29(12):2283-6. PubMed ID: 2977624
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
    Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ANTIHEPARIN AND ANTIFIBRINOLYTIC ACTIVITY OF BLOOD IN PATIENTS WITH ATHEROSCLEROSIS.
    MYASNIKOV AL; CHAZOV EI
    Am Heart J; 1964 Jan; 67():18-22. PubMed ID: 14110659
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of alpha 2 plasmin inhibitor and alpha 2 plasmin inhibitor-plasmin complex by enzyme immunoassay method--with special reference to accident surgery].
    Fukuda C; Iijima K; Inoue N; Takashima Y; Urabe C; Nakamura K
    Rinsho Byori; 1988 Mar; 36(3):346-50. PubMed ID: 2969986
    [No Abstract]   [Full Text] [Related]  

  • 39. Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid.
    Inman RD; Harpel PC
    J Rheumatol; 1986 Jun; 13(3):535-7. PubMed ID: 2942685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [alpha 2-Plasmin inhibitor-plasmin complex (PIC)].
    Yoshikawa Y; Sakata Y
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():55-8. PubMed ID: 8753179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.